Loading Events
  • This event has passed.

Assessing and Promoting Bone Health Across the Lifespan

May 18, 2022 @ 12:00 pm - 12:45 pm EDT


In the United States, there are more than 100 diagnostic tests and procedures available for detecting diseases and monitoring their progression. Diagnostic tools are also used to guide treatments and evaluate their effectiveness. Some tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.

Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women.

SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events will discuss how to improve health outcomes for diseases and conditions that disproportionately or exclusively affect women, with special a focus on cancers, reproductive health, and bone health.

The SWHR Value of Diagnostics within Women’s Health series includes:


May 18, 2022
12:00 pm - 12:45 pm EDT
Event Categories:




  • Discuss the impacts of bone health on women’s health across the lifespan, including disparities in disease burden (i.e., osteoporosis and arthritis) and access to care 
  • Highlight diagnostic tests for bone density and fracture and key considerations for disease management   
  • Emphasizing ways to empower women and improve quality of care and healthy aging 


Laura L. Tosi, MD
Director, Bone Health Program, Children's National
Laura L. Tosi, MD
Director, Bone Health Program, Children's National

Laura L. Tosi, M.D., is the director of the Bone Health Program at Children’s National Hospital. Her practice focuses on orthopaedic management of children with physical disabilities and birth defects. Dr. Tosi also works to increase physician awareness of bone health issues for women and children, with the goal of reducing debilitating bone injury as the population ages. Dr. Tosi also treats children and adults with spina bifida and other congenital orthopaedic problems. Dr. Tosi has lectured extensively on women’s bone health, particularly osteoporosis prevention, to women’s organizations throughout the United States. Dr. Tosi is a member of the Committee on Women’s Health Issues for the American Academy of Orthopaedic Surgeons and serves on the Boards of Directors for the Orthopaedic Research and Education Foundation and the Academic Orthopaedic Society. 

Alana C. Serota, MD, CCFP, CCD
Ambulatory Care Physician, Department of Metabolic Bone Disease, Hospital for Special Surgery
Alana C. Serota, MD, CCFP, CCD
Ambulatory Care Physician, Department of Metabolic Bone Disease, Hospital for Special Surgery

Dr. Serota completed training in primary care medicine in Canada. Her clinical duties and research focused on general women’s health, osteoporosis care, contraceptive technologies, and access to same. She then went on to complete a Fellowship in Women’s Health with an emphasis on gynecology and internal medicine relevant to the health of women at centers of excellence throughout Ontario. She was certified as a Menopause Practitioner by the North American Menopause Society in 2002. Dr. Serota’s second fellowship was in osteoporosis and metabolic bone disease at the Hospital for Special Surgery. This further focused her interests to the study of bone health in women and men from the late teenage years onward. Her current clinical interests include maintenance and improvement of bone health throughout life, especially premenopausal and perimenopausal women, and optimization of bone health and healing before, during, and after surgical orthopedic procedure. She is committed to a patient-centered, biopsychosocial approach to the care of osteoporosis and metabolic bone issues. 


SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains editorial control and independence over educational content.